Ayurvedic drug for fungal skin disease

PHARMACOGNOSTICAL AND CLINICAL STUDY OF APAMARGA(Achyranthes aspera Linn.)BHASMA PRALEPA IN THE MANAGEMENT OF SIDHMA KUSHTA - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067925

Enrollment

Registered

2024-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B360- Pityriasis versicolor

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with signs and symptoms of Sidhma Kushta. 2.Patients of both gender with age limit of 20 years to 60 years. 3.Patients with positive KOH culture and positive sign showing in WOODs LAMP examination. 4.Patients who are willing to complete the given treatment schedule. 5.Patients with onset of diesase more or less than 1 to 2 years.

Exclusion criteria

Exclusion criteria: 1.Patients of age below 20 years and above 60 years. 2.Patients with psycho-somatic disorders. 3.Pregnant women and lactating mothers. 4.Patients suffering from chronic illness like DM, HIV,HBsAg,CKD,CAD.

Design outcomes

Primary

Measure	Time frame
Usage of Apamarga Bhasma gel for 7 weeks topical application-Reduction in size, number of patches,coming back to normal skin tone and reduction in associated symptomsTimepoint: 0th day,15th day,30th day,45th day	—

Secondary

Measure	Time frame
To improve the quality of life of patientTimepoint: 0th day,15th day,30th day,45th day	—

Countries

India

Contacts

Public ContactDr A Vijaya Lakshmi

Dr.BRKR Government Ayurvedic Medical College

vijayalakshmiayanam@gmail.com9849314525

Outcome results